Streetbeat News

Products Services

ABT

Abbott Laboratories (ABT) is trading at a discounted price-to-book value, making it an attractive option for investors. The company has a strong position in point-of-care testing, focusing on areas such as Infectious Disease, Cardiometabolic & Informatics, Toxicology, and Consumer Diagnostics.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

NVDA

Nvidia Corporation's recent announcements at CES, including new AI hardware and partnerships, have led to a Buy rating upgrade. The launch of Project DIGITS, an affordable AI supercomputer, is expected to significantly boost Nvidia's revenue. Nvidia's leadership in AI, autonomous vehicles, and robotics is highlighted, enhancing its long-term growth prospects.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

NVDA

TSM

Semiconductor companies, including Nvidia and Taiwan Semiconductor (TSM), are actively seeking funding from the CHIPS Act. Nvidia is a prominent player in the stock market, while TSM has also shown strong performance.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

VIAV

Viavi Solutions Inc. (VIAV) is providing precision optical filter components for NASA's Europa Clipper mission. These components are crucial for the mission's success, highlighting Viavi's role in advanced space exploration technologies.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

SNAP

Snap Inc. (SNAP) is recommended as a buy due to its strong AI and AR strategies, despite a 27.5% stock decline over the past year. The company boasts 443 million daily users, indicating potential for recovery.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

KVYO

Klaviyo has been recognized as the top email marketing tool by Consumer365, praised for its advanced automation, seamless integrations, and powerful analytics that drive business growth and optimize marketing strategies.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

HOTH

Hoth Therapeutics' stock surged after a successful mid-stage study showed significant improvement in skin toxicities for cancer patients treated with HT-001. This positive outcome is related to EFGR inhibitor therapy.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

EIX

Edison International's stock is experiencing a significant drop due to power shutoffs prompted by wildfires. This marks the largest daily percentage decrease since March 2020.

Portfolio Pulse from

January 08, 2025 | 5:00 pm

AAAU

Gold prices have increased due to technical buying and strong demand from China. This development is significant for investors in gold-related assets.

Portfolio Pulse from

January 08, 2025 | 4:45 pm

SANA

Sana Biotechnology's stock surged over 200% following positive results from its first in-human diabetes trial, with no safety issues observed four weeks post-transplant of its UP421 therapy.

Portfolio Pulse from

January 08, 2025 | 4:45 pm